Avastin (bevacizumab) is a prescription drug used to treat certain types of cancer. Avastin is also available as a biosimilar drug. It’s prescribed for adults ages 18 years and older. Avastin comes as ...
A review article investigating the use of bevacizumab biosimilars found that despite lingering concerns about their usage for extrapolated indications, bevacizumab biosimilars are regularly used in ...
In a phase II trial, 99 patients were randomly assigned to bevacizumab 7.5 (n = 32) or 15 mg/kg (n = 35) plus carboplatin (area under the curve = 6) and paclitaxel (200 mg/m 2) every 3 weeks or ...
Epigenetic and phenotypic signatures of T-cell response to blinatumomab in pediatric relapsed and refractory B-ALL. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract ...
Morning Overview on MSN
A new drug combo shrank treatment-resistant colon cancer in a large clinical trial
Patients with metastatic colorectal cancer that had stopped responding to at least two prior treatment regimens gained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results